Loading organizations...
Biopharmaceutical company targeting Alzheimer's drug discovery.
Oligomerix has raised $7.5M across 3 funding rounds.
Oligomerix has raised $7.5M in total across 3 funding rounds.
Oligomerix has raised $7.5M in total across 3 funding rounds.
Oligomerix's investors include Durand Venture Associates, Wheatley MedTech Partners, Wheatley Partners.
Oligomerix has raised $7.5M across 3 funding rounds. Most recently, it raised $2.7M Series B Extension in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 2, 2022 | $2.7M Series B Extension | ||
| May 22, 2013 | $2.8M Series B | ||
| Apr 23, 2012 | $2.0M Series A | Durand Venture Associates, Wheatley MedTech Partners, Wheatley Partners |